Fig. 3
From: Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
Effects of SLC31A1 expression on disease-free survival in different TCGA tumor types. GEPIA2 is used to build a survival map (a) and conduct disease-free survival b–f analyses. Kaplan–Meier plots of cancer types with significant results are displayed. The 95% confidence intervals of disease-free survival are indicated by red and blue lines for the high and low SLC31A1 groups, respectively. The color of the squares indicates the value of the hazzard ratio (HR). Squares with bold outlines in the survival map denote p(HR) < 0.05